Ticker Scorecard - ETON Basics Company: Eton Pharmaceuticals, Inc. Common Stock IPO Date: November 13, 2018 Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic Market Cap: $378.01M Activated in VL: True Average Daily Range Avg Daily Range: $0.15 | 2.75% Avg Daily Range (30 D): $0.55 | 3.52% Avg Daily Range (90 D): $0.41 | 3.14% Institutional Daily Volume Avg Daily Volume: .18M Avg Daily Volume (30 D): .3M Avg Daily Volume (90 D): .24M Trade Size Avg Trade Size (Sh.): 149 Avg Trade Size (Sh.) (30 D): 71 Avg Trade Size (Sh.) (90 D): 80 Institutional Trades Total Inst.Trades: 13 Avg Inst. Trade: $1.57M Avg Inst. Trade (30 D): $.51M Avg Inst. Trade (90 D): $.72M Avg Inst. Trade Volume: .24M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.09M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 610.33K     News May 9, 2024 @ 8:01 PM Eton Pharmaceuticals Reports First Quarter 2024 Fi... Source: Eton Pharmaceuticals May 1, 2024 @ 8:05 PM Eton Pharmaceuticals to Present at the Citizens JM... Source: Eton Pharmaceuticals Apr 30, 2024 @ 11:00 AM Eton Pharmaceuticals Announces Submission to FDA o... Source: Eton Pharmaceuticals Apr 29, 2024 @ 8:30 PM Eton Pharmaceuticals to Report First Quarter 2024 ... Source: Eton Pharmaceuticals Mar 22, 2024 @ 6:00 AM Eton Pharmaceuticals Announces Acquisition of PKU... Source: Eton Pharmaceuticals Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.21 $.02 $-.12 Diluted EPS $.02 $-.12 Revenue $ 34.68M $ 10.32M $ 9.07M Gross Profit $ 20.57M $ 6.3M $ 5.63M Net Income / Loss $ -5.48M $ .63M $ -3.04M Operating Income / Loss $ -5.22M $ .51M $ -2.94M Cost of Revenue $ 14.11M $ 4.02M $ 3.45M Net Cash Flow $ 3.96M $ 2.57M $ 1.04M PE Ratio